Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Clinical trial NCT02873520 · UNKNOWN

Trial details

NCT number: NCT02873520
Sponsor: Ningbo Cancer Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Precision Cell Immunotherapy Chemotherapy Advanced Gastric Cancer

Start date: 2016-08-01
Primary completion: 2018-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.